Exercise-priming of CBT for Depression: the CBT+ Trial
This study investigates the effects of intentionally sequencing aerobic exercise immediately prior to cognitive behavioral therapy (CBT) to determine its effects on mechanisms of CBT (i.e., working alliance, behavioral activation). To assess the utility of this treatment augmentation, investigators will conduct a randomized controlled trial involving 100 adults with Major Depressive Disorder who will watch a nature documentary while either resting quietly ( 'CalmCBT') or exercising at a moderate intensity…
Conditions studied
Major Depressive Disorder
About this study
This study investigates the effects of intentionally sequencing aerobic exercise immediately prior to cognitive behavioral therapy (CBT) to determine its effects on mechanisms of CBT (i.e., working alliance, behavioral activation). To assess the utility of this treatment augmentation, investigators will conduct a randomized controlled trial involving 100 adults with Major Depressive Disorder who will watch a nature documentary while either resting quietly ( 'CalmCBT') or exercising at a moderate intensity ('ActiveCBT') immediately prior to 8 weekly sessions of CBT.
Interventions
- Behavioral: Rest — 30 minutes of rest while watching a nature documentary before cognitive behavioral therapy
- Behavioral: Aerobic Activity — 30 minutes of aerobic activity before cognitive behavioral therapy, while watching the same nature documentary the CalmCBT group watches.
Primary outcomes
- Working Alliance Inventory (WAI) - Bond subscale (data collected at each CBT session (weeks 1-8))
- Behavioral Activation for Depression Scale (BADS) (data collected at baseline, each CBT session (weeks 1-8), post intervention visit (week 9), week 20, week 52)
- GRID Hamilton Rating Scale for Depression (GRID-HAMD) (baseline, post intervention visit (week 9), week 20, week 52)
- Patient Health Questionnaire-9 (PHQ-9) (data collected at baseline, each CBT session (weeks 1-8), post intervention visit (week 9), week 20, week 52)
Eligibility information
Study locations
- University of Wisconsin, Madison, Wisconsin 53792 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-13.